| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | DE102005029372A1 Selektive Hemmstoffe humaner corticoidsynthasen Selective inhibitors of human corticoidsynthasen |
| 01/04/2007 | CA2612623A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612619A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612614A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/03/2007 | EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives |
| 01/03/2007 | EP1737812A1 Methods of amination |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | CN1890225A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/03/2007 | CN1890223A Capsaicin receptor agonists |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/03/2007 | CN1293034C New gamma selective retinoids |
| 01/03/2007 | CN1292744C Carboxylic acid derivs. that inhibit binding of integrins to their receptors |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | US7157408 5,7-Dibromo-8-(2-hydroxyethyl) quinoline and 5,7-dibromo-8-(2-methoxycarbonyloxyethyl) quinoline, for treating plant diseases |
| 01/02/2007 | CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 01/02/2007 | CA2225628C Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 12/28/2006 | WO2006137789A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 12/28/2006 | WO2006137474A1 Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same |
| 12/28/2006 | WO2006137376A1 Amide derivative and pesticide containing such compound |
| 12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
| 12/28/2006 | US20060293352 Phenoxiacetic acid derivatives |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293333 Therapeutic amides |
| 12/28/2006 | US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents |
| 12/28/2006 | US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 12/28/2006 | DE102005017286B3 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 12/28/2006 | CA2613001A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators |
| 12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735275A2 Aryl sulfones and uses related thereto |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1886379A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/27/2006 | CN1886134A Salts and polymorphs of a potent antidiabetic compound |
| 12/27/2006 | CN1884264A Method for synthesizing 2-methyl-3-hydroxy-6-isopropyl quinolyl-4-carboxylic acid |
| 12/27/2006 | CN1884253A Organic compound containing heteroatoms and its use in Zigler-Natta catalyst |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/27/2006 | CN1291977C Polysubstituted quinoline derivative functional material, and preparing method and thereof |
| 12/27/2006 | CN1291976C Antiretroviral pyridine and quinoline derivatives |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153865 N-type calcium channel antagonists for the treatment of pain |
| 12/21/2006 | WO2006134040A1 Anthranilic acid derivatives |
| 12/21/2006 | WO2006133942A1 NOVEL SALT FORM OF A β2 -ADRENERGIC AGONIST QUINOLIN-2-ONE DERIVATIVE |
| 12/21/2006 | WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 12/21/2006 | WO2006034235A3 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 12/21/2006 | WO2006008750A3 Methyl 2-[(3s)-[3-[(2e)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates |
| 12/21/2006 | WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 12/21/2006 | WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 12/21/2006 | US20060287396 4-aryl quinols and analogs thereof as therapeutic agents |
| 12/21/2006 | US20060287334 e.g. 8-(4-(4-Fluorobenzyl)-piperazin-1-yl)-3-phenylsulfonylquinoline; serotonin receptor modulator; antidepressant, anxiolytic agent, cognition activator; schizophrenia, obesity, Alzheimer's disease |
| 12/21/2006 | DE102005018026B4 Substituierte Styrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted styrenes, processes for their preparation and their use as anti-inflammatories |
| 12/21/2006 | CA2611910A1 Anthranilic acid derivatives |
| 12/21/2006 | CA2611893A1 Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5 |
| 12/20/2006 | EP1732897A1 Quinolone carboxylic acid derivatives for treatment of hyperproliferative conditions |
| 12/20/2006 | EP1732541A2 Cyclic compounds |
| 12/20/2006 | EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 12/20/2006 | EP1511732B1 Process for the manufacture of quinoline derivatives |
| 12/20/2006 | EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/20/2006 | CN1882560A Heterocompound and its production and usage method |
| 12/20/2006 | CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 12/20/2006 | CN1882546A Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 12/20/2006 | CN1879624A 5-ht 1a receptor subtype agonists |
| 12/20/2006 | CN1290834C Quinoline derivatives and their use as antibiotics |
| 12/19/2006 | US7151180 3-((hetero)arylthio)-1,2-dihydroquinolin-2-ones such as 3-[(4-aminophenyl)thio]-4-(5-chloro-2-hydroxyphenyl)-6-(trifluoromethyl)-2(1H)-quinoline; erectile dysfunction and irritable bowel syndrome |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/19/2006 | US7150876 Methods for stabilizing ingredients within cosmetics, personal care and household products |
| 12/19/2006 | CA2297439C Carbostyril derivatives |
| 12/19/2006 | CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases |
| 12/14/2006 | WO2006132192A1 Novel 2-quinolone derivative |
| 12/14/2006 | WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 12/14/2006 | WO2006131782A1 Process for the manufacture of methyl-2-(3-(2-(7-chloro-2-quinolinyl-ethenyl)-phenyl)-3-oxopropyl) benzoate |
| 12/14/2006 | WO2006131519A1 Quinoline derivatives as antibacterial agents |
| 12/14/2006 | WO2005120497A3 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 12/14/2006 | US20060281949 Method for production $g(a),$g(b)-unsaturated amide compounds |
| 12/14/2006 | US20060281629 Catalyzing the oxidation, carbonylation, nitration, sulfonation reaction; catalyst selectivity; produce terephthalic acid from p-xylene or from p-toluic acid; produce pyromellitic acid from durene |
| 12/14/2006 | DE102005027169A1 Tetrahydrochinolinderivate Tetrahydroquinoline |
| 12/14/2006 | DE102005027168A1 Tetrahydrochinoline Tetrahydroquinolines |
| 12/13/2006 | EP1731511A1 BicyclischeI heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 12/13/2006 | EP1731507A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 12/13/2006 | EP1731505A1 Alkoxyphenylpropanoic acid derivatives |
| 12/13/2006 | EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same |
| 12/13/2006 | EP1730135A1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc) |
| 12/13/2006 | EP1730113A1 Process for the synthesis of a cxcr4 antagonist |
| 12/13/2006 | EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 12/13/2006 | EP1730103A1 Formamide derivatives useful as adrenoceptor |
| 12/13/2006 | EP1729773A1 8-hydroxy-5- [(-hydroxy-2- [[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | CN1878770A Novel hypocholesterolemic compounds |
| 12/13/2006 | CN1878765A Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors |